After the Bell
Before the Bell
Jim Cramer's Daily Booyah
Winners & Losers
Biotech columnist Adam Feuerstein answers readers' questions about health care.
The company was never as bad as it was once perceived to be.
Biotech M&A deals that haven't happened because of price argue against the risk of a bubble.
Trade-Ideas LLC identified Onyx Pharmaceuticals (ONXX) as a "water-logged and getting wetter" (weak stocks crossing below support with today's range greater than 200%) candidate
©1996-2016 TheStreet, Inc. All rights reserved.
Action Alerts PLUS is a registered trademark of TheStreet, Inc.